Quarterly report pursuant to Section 13 or 15(d)

Note 9 - Debt

v3.20.1
Note 9 - Debt
9 Months Ended
Mar. 31, 2020
Notes to Financial Statements  
Debt Disclosure [Text Block]
(
9
)
Debt
 
Total debt obligations at
March 31, 2020
and
June 30, 2019
consist of the following (in thousands):
 
   
March 31,
   
June 30,
 
   
2020
   
2019
 
                 
Borrowings under revolving credit facility
  $
100,000
    $
-
 
Capital leases
(1)
   
-
     
1,066
 
Total debt
   
100,000
     
1,066
 
Less current maturities
   
-
     
550
 
Total long-term debt
  $
100,000
    $
516
 
 
 
 
(
1
)
Capital leases were previously reported as debt as of
June 30, 2019.
Upon the adoption of the new leasing standard, the Company reclassified its capital lease obligations from short and long-term debt to other current liabilities and other long-term liabilities, respectively. Refer to Note
7
for further details regarding capital lease obligations.
 
Credit Agreement
 
On
December 21, 2018,
the Company and most of its domestic subsidiaries (the “Loan Parties”) entered into a Second Amended and Restated Credit Agreement (the “Credit Agreement”) with JPMorgan Chase Bank, N.A. as administrative agent and syndication agent and Capital One, National Association, as documentation agent. The Credit Agreement provides for a
$165
million revolving credit facility (the “Facility”), subject to borrowing base availability, with the maturity date of
December 21, 2023.
We incurred financing costs of
$0.6
million, which are being amortized over the remaining life of the Facility using the effective interest method.
 
At the Company’s option, revolving loans under the Facility bear interest, based on the average availability, at an annual rate of either (a) the London Interbank Offered rate (“LIBOR”) plus
1.5%
to
2.0%,
or (b) the higher of (i) the prime rate, (ii) the federal funds effective rate plus
0.5%,
or (iii) LIBOR plus
1.0%
plus in each case
0.5%
to
1.0%.
 
The availability of credit at any given time under the Facility will be constrained by the terms and conditions of the Facility, including the amount of collateral available, a borrowing base formula based upon numerous factors, including the value of eligible inventory and eligible accounts receivable, and other restrictions contained in the Facility. All obligations under the Facility are secured by assets of the Loan Parties, including inventory, receivables and certain types of intellectual property.
 
 
Borrowings
under the Facility
 
On
March 23, 2020,
we provided notice to the administrative agent under the Credit Agreement to borrow a principal amount of
$80
million under the Facility. Subsequently, on
March 30, 2020,
we borrowed an additional
$20
million, bringing our aggregate borrowings to
$100
million under the Facility as of
March 31, 2020.
Prior to such notice, there were
no
borrowings outstanding under the Facility. The borrowings bear a weighted average interest rate equal to the
one
-month LIBOR rate of
0.95%
plus a spread using a debt leverage pricing grid, currently at
1.50%.
Interest on the borrowings outstanding is payable monthly in arrears and the principal balance is payable on the maturity date of
December 21, 2023.
We elected to draw down on the Facility to increase our cash position as a precautionary measure and to preserve financial flexibility in consideration of the disruption and uncertainty surrounding the ongoing COVID-
19
pandemic.
 
The outstanding borrowings of
$100
million are reported as 
Long-term debt
 within the consolidated balance sheet at
March 31, 2020.
For the
nine
months ended
March 31, 2020
and
2019,
we recorded interest expense of
$0.2
million and
$0.3
million, respectively, on our outstanding debt.
 
The fair value of our long-term debt was
$100
 million as of
March 31, 2020,
which we believe approximates the carrying amount as the terms and interest rate approximate market rates given its floating interest rate basis.
 
Covenants and Other Ratios
 
The Facility contains various restrictive and affirmative covenants, including required financial reporting, limitations on the ability to grant liens, make loans or other investments, incur additional debt, issue additional equity, merge or consolidate with or into another person, sell assets, pay dividends or make other distributions or enter into transactions with affiliates, along with other restrictions and limitations similar to those frequently found in credit agreements of this type and size. Loans under the Facility
may
become immediately due and payable upon certain events of default (including failure to comply with covenants, change of control or cross-defaults) as set forth in the Facility.
 
The Facility does
not
contain any significant financial ratio covenants or coverage ratio covenants other than a fixed charge coverage ratio covenant based on the ratio of (a) EBITDA, plus cash Rentals, minus Unfinanced Capital Expenditures to (b) Fixed Charges, as such terms are defined in the Facility (the “FCCR Covenant”). The FCCR Covenant only applies in certain limited circumstances, including when the unused availability under the Facility falls below
$18.5
million. The FCCR Covenant ratio is set at
1.0
and measured on a trailing
twelve
-month basis.
 
At
March 31, 2020
and
June 30, 2019,
there was
$5.8
million and
$6.1
million, respectively, of standby letters of credit outstanding under the Facility. Total borrowing base availability under the Facility was
$23.9
million at
March 31, 2020
and
$158.9
million at
June 30, 2019.
At both
March 31, 2020
and
June 30, 2019,
we were in compliance with all the covenants under the Facility.